Serum ferritin concentration is associated with plasma levels of cholesterol oxidation products in man

Free Radical Biology and Medicine

Volumn 35, Issue 8, 2003, Pages 922-928

  Tuomainen, Tomi Pekka ^a   Diczfalusy, Ulf ^b   Kaikkonen, Jari ^c   Nyyssönen, Kristiina ^a   Salonen, Jukka T ^a,d  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Oy Jurilab Ltd   (Finland)

^d Inner Savo Health Centre   (Finland)

Author keywords

Autoxidation; Cholesterol oxidation; Ferritin; Free radicals; Iron; LDL; Oxysterol

Indexed keywords

24 HYDROXYCHOLESTEROL; 25 HYDROXYCHOLESTEROL; 26 HYDROXYCHOLESTEROL; 7 OXOCHOLESTEROL; 7ALPHA HYDROXYCHOLESTEROL; 7BETA HYDROXYCHOLESTEROL; CHOLESTANE DERIVATIVE; CHOLESTANETRIOL; CHOLESTEROL 5ALPHA,6ALPHA OXIDE; CHOLESTEROL 5BETA,6BETA OXIDE; CHOLESTEROL DERIVATIVE; FERRITIN; OXYSTEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOOXIDATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; FERRITIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL;

EID: 0141526416     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(03)00433-7     Document Type: Article

References (37)

1. Halliwell B., Gutteridge J.M. Role of free radicals and catalytic metal ions in human disease an overview . Methods Enzymol. 186:1990;1-85.
2. Salonen J.T., Nyyssönen K., Korpela H., Tuomilehto J., Seppänen R., Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 86:1992;803-811.
3. Tuomainen T.-P., Punnonen K., Nyyssönen K., Salonen J.T. Association between body iron stores and the risk of acute myocardial infarction in men. Circulation. 97:1998;1461-1466.
4. Witztum J.L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88:1991;1785-1792.
5. Salonen J.T., Ylä-Herttuala S., Yamamoto R., Butler S., Korpela H., Salonen R., Nyyssönen K., Palinski W., Witztum J.L. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet. 339:1992;883-887.
6. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272:1997;20963-20966.
7. Smith L.L., Johnson B.H. Biological activities of oxysterols. Free Radic. Biol. Med. 7:1989;285-332.
8. Brown A.J., Jessup W. Oxysterols and atherosclerosis. Atherosclerosis. 142:1999;1-28.
9. Russell D.W. Oxysterol biosynthetic enzymes. Biochim. Biophys. Acta. 1529:2000;126-135.
10. Meaney S., Hassan M., Sakinis A., Lütjohann D., von Bergmann K., Wennmalm A., Diczfalusy U. Björkhem, I. Evidence that the major oxysterols in human circulation originate from distinct pools of cholesterol a stable isotope study . J. Lipid Res. 42:2001;70-78.
11. Salonen J.T. Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. Ann. Clin. Res. 20:1988;46-50.
12. MONICA Manual, Part IV, Event Registration. http://wwwktl.fi/publications/monica/manual/index.htm.
13. Dzeletovic S., Breuer O., Lund E., Diczfalusy U. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal. Biochem. 225:1995;73-80.
14. Nyyssönen K., Kaikkonen J., Salonen J.T. Characterization and determinants of an electronegatively charged low-density lipoprotein in human plasma. Scand. J. Clin. Lab. Invest. 56:1996;681-689.
15. Lakka T.A., Venäläinen J.M., Rauramaa R., Salonen R., Tuomilehto J., Salonen J.T. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. N. Engl. J. Med. 330:1994;1549-1554.
16. Kauhanen J., Kaplan G.A., Goldberg D.E., Salonen J.T. Beer binging and mortality results from the Kuopio ischaemic heart disease risk factor study, a prospective population based study . BMJ. 315:1997;846-851.
17. Bretillon L., Lütjohann D., Ståhle L., Widhe T., Bindl L., Eggertsen G., Diczfalusy U., Björkhem I. Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface. J. Lipid Res. 41:2000;840-845.
18. Lusis A.J. Atherosclerosis. Nature. 407:2000;233-241.
19. Sullivan J.L. Iron and the sex difference in heart disease risk. Lancet. 1:1981;1293-1294.
20. Salonen J.T. Body iron stores, lipid peroxidation and coronary heart disease. Hallberg L., Asp N.-G. Iron nutrition in health and disease. 1996;293-301 John Libbey & Company Ltd, London.
21. Meyers D.G. The iron hypothesis - does iron cause atherosclerosis? Clin. Cardiol. 19:1996;925-929.
22. Danesh J., Appleby P. Coronary heart disease and iron status. Meta-analyses of prospective studies. Circulation. 99:1999;852-854.
23. Salonen J.T., Korpela H., Nyyssönen K., Porkkala E., Tuomainen T.-P., Belcher J.D., Jacobs D.R. Jr., Salonen R. Lowering of body iron stores by blood letting and oxidation resistance of serum lipoproteins a randomized cross-over trial in male smokers . J. Intern. Med. 237:1995;161-168.
24. Tuomainen T.-P., Nyyssönen K., Porkkala-Sarataho E., Salonen R., Baumgartner J.A., Geisser P., Salonen J.T. Oral supplementation with ferrous sulfate but not with non-ionic iron polymaltose complex increases the suspectibility of plasma lipoproteins to oxidtation. Nutr. Res. 19:1999;1121-1132.
25. Colles S.M., Maxson J.M., Carlson S.G., Chisolm G.M. Oxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterols. Trends Cardiovasc. Med. 11:2001;131-138.
26. Lund E.G., Kerr T.A., Sakai J., Li W.P., Russell D.W. cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism. J. Biol. Chem. 273:1998;34316-34327.
27. Salonen J.T., Nyyssönen K., Salonen R., Porkkala-Sarataho E., Tuomainen T.-P., Diczfalusy U., Björkhem I. Lipoprotein oxidation and progression of carotid atherosclerosis. Circulation. 95:1997;840-845.
28. Vaya J., Aviram M., Mahmood S., Hayek T., Grenadir E., Hoffman A., Milo S. Selective distribution of oxysterols in atherosclerotic lesions and human plasma lipoproteins. Free Radic. Res. 34:2001;485-497.
29. Garcia-Cruset S., Carpenter K.L., Guardiola F., Stein B.K., Mitchinson M.J. Oxysterol profiles of normal human arteries, fatty streaks and advanced lesions. Free Radic. Res. 35:2001;31-41.
30. Leggett B.A., Brown N.N., Bryant S.J., Duplock L., Powell L.W., Halliday J.W. Factors affecting the concentrations of ferritin in serum in a healthy Australian population. Clin. Chem. 36:1990;1350-1355.
31. Lipschitz D.A., Cook J.D., Finch C.A. A clinical evaluation of serum ferritin as an index of iron stores. 1974. Nutrition. 8:1992;443-447.
32. Cutteridge J.M.C. Iron and free radicals. Hallberg L., Asp N.-G. Iron nutrition in health and disease. 1996;239-246 John Libbey & Company Ltd, London.
33. Burkitt M.J., Milne L., Raafat A. A simple, highly sensitive and improved method for the measurement of bleomycin-detectable iron the 'catalytic iron index' and its value in the assessment of iron status in haemochromatosis . Clin. Sci. (Lond.). 100:2001;239-247.
34. Bolann B.J., Ulvik R.J. On the limited ability of superoxide to release iron from ferritin. Eur. J. Biochem. 193:1990;899-904.
35. 2 inhalation technique and mass isotopomer distribution analysis to study oxygenation of cholesterol in rat. Evidence for in vivo formation of 7-oxo-, 7β-hydroxy-, 24-hydroxy-, and 25-hydroxycholesterol. J. Biol. Chem. 270:1995;20278-20284.
36. Emanual H.A., Hassel C.A., Addis P.B., Bergmann S.D., Zavoral J.W. Plasma cholesterol oxidation products (oxysterols) in human subjects fed a meal rich in oxysterols. J. Food Sci. 56:1991;843.
37. Lyons M.A., Samman S., Gatto L., Brown A.J. Rapid hepatic metabolism of 7-ketocholesterol in vivo implications for dietary oxysterols . J. Lipid. Res. 40:1999;1846-1857.